Loading…

Correlation of Cholestasis With Serum Copper and Whole-Blood Manganese Levels in Pediatric Patients

Many institutions reduce or eliminate copper (Cu) and manganese (Mn) in parenteral nutrition (PN) solutions when cholestasis develops. Little data exist to support this practice. Fifty-four subjects with known serum Cu, whole-blood Mn, and serum-conjugated bilirubin levels were evaluated in this pro...

Full description

Saved in:
Bibliographic Details
Published in:Nutrition in clinical practice 2008-04, Vol.23 (2), p.161-165
Main Authors: McMillan, Nancy B., Mulroy, Cecilia, MacKay, Mark W., McDonald, Catherine M., Jackson, W. Daniel
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3811-4159f23255eb6fe51197f34bc05ed4cddfd5a13699c74e63a27287c5521d3f183
cites cdi_FETCH-LOGICAL-c3811-4159f23255eb6fe51197f34bc05ed4cddfd5a13699c74e63a27287c5521d3f183
container_end_page 165
container_issue 2
container_start_page 161
container_title Nutrition in clinical practice
container_volume 23
creator McMillan, Nancy B.
Mulroy, Cecilia
MacKay, Mark W.
McDonald, Catherine M.
Jackson, W. Daniel
description Many institutions reduce or eliminate copper (Cu) and manganese (Mn) in parenteral nutrition (PN) solutions when cholestasis develops. Little data exist to support this practice. Fifty-four subjects with known serum Cu, whole-blood Mn, and serum-conjugated bilirubin levels were evaluated in this prospective, observational study. Subjects ranged in weight from 760 g to 65.2 kg. Subjects weighing
doi_str_mv 10.1177/0884533608314529
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70483997</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0884533608314529</sage_id><sourcerecordid>70483997</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3811-4159f23255eb6fe51197f34bc05ed4cddfd5a13699c74e63a27287c5521d3f183</originalsourceid><addsrcrecordid>eNqFkM1LxDAQxYMoun7cPUlO3qqZpmnaoxa_YNUFlT2WbDJdI91mTVrF_94suyAI4mkY5vce8x4hx8DOAKQ8Z0WRCc5zVnDIRFpukRGUGSRpXLbJaHVOVvc9sh_CG2NQcFnskr04SyYLPiK6ct5jq3rrOuoaWr26FkOvgg10avtX-oR-WNDKLZfoqeoMna6I5LJ1ztB71c1VhwHpGD-wDdR2dILGqt5bTSfRFbs-HJKdRrUBjzbzgLxcXz1Xt8n48eauuhgnmhcASQaibFKeCoGzvEEBUMqGZzPNBJpMG9MYoYDnZallhjlXqUwLqYVIwfAmRjogp2vfpXfvQ0xRL2zQ2LbxRTeEWrIs5i5lBNka1N6F4LGpl94ulP-qgdWrYuvfxUbJycZ7mC3Q_Ag2TUZArIFP2-LXv4b1QzVhkEPUJWtdUHOs39zgu9jR3498A-wDjtw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70483997</pqid></control><display><type>article</type><title>Correlation of Cholestasis With Serum Copper and Whole-Blood Manganese Levels in Pediatric Patients</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>McMillan, Nancy B. ; Mulroy, Cecilia ; MacKay, Mark W. ; McDonald, Catherine M. ; Jackson, W. Daniel</creator><creatorcontrib>McMillan, Nancy B. ; Mulroy, Cecilia ; MacKay, Mark W. ; McDonald, Catherine M. ; Jackson, W. Daniel</creatorcontrib><description>Many institutions reduce or eliminate copper (Cu) and manganese (Mn) in parenteral nutrition (PN) solutions when cholestasis develops. Little data exist to support this practice. Fifty-four subjects with known serum Cu, whole-blood Mn, and serum-conjugated bilirubin levels were evaluated in this prospective, observational study. Subjects ranged in weight from 760 g to 65.2 kg. Subjects weighing &lt;25 kg received a daily parenteral dose of 20μ g/kg Cu and 5 μg/kg Mn. Subjects weighing ≥25 kg received a dose of 500 μg/d Cu and 150 μg/d Mn. Cholestasis was defined as a conjugated bilirubin level ≥2 mg/dL. Of the 54 subjects, 20 had cholestasis. Fifteen patients had elevated Cu levels, and 21 had high Mn levels. Seven of the subjects had both high Cu and high Mn levels. The regression model comparing cholestasis as a predictor of high, low, or normal Cu level was not significant (P = .9588). Cholestasis was not a significant predictor of high, low, or normal Mn levels (P = .6533). No correlation between Cu and Mn levels was found. The authors found no significant relationship between conjugated serum bilirubin levels ≥2.0 mg/dL, serum Cu, and whole-blood Mn levels. They found insufficient evidence to support the practice of dosing Mn from a Cu level or vice versa. They recommend obtaining Cu and Mn levels on all pediatric patients who develop cholestasis prior to adjusting parenteral doses and at regular intervals for all long-term PN patients.</description><identifier>ISSN: 0884-5336</identifier><identifier>EISSN: 1941-2452</identifier><identifier>DOI: 10.1177/0884533608314529</identifier><identifier>PMID: 18390783</identifier><language>eng</language><publisher>United States: SAGE Publications</publisher><subject>Adolescent ; Bilirubin - blood ; Body Weight - physiology ; Child ; Child, Preschool ; cholestasis ; Cholestasis - blood ; copper ; Copper - administration &amp; dosage ; Copper - blood ; Dose-Response Relationship, Drug ; Female ; Humans ; Infant ; Male ; manganese ; Manganese - administration &amp; dosage ; Manganese - blood ; Nursing ; parenteral nutrition ; Parenteral Nutrition - adverse effects ; pediatric ; Prospective Studies ; Reference Values</subject><ispartof>Nutrition in clinical practice, 2008-04, Vol.23 (2), p.161-165</ispartof><rights>American Society for Parenteral and Enteral Nutrition</rights><rights>2008 by The American Society for Parenteral and Enteral Nutrition</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3811-4159f23255eb6fe51197f34bc05ed4cddfd5a13699c74e63a27287c5521d3f183</citedby><cites>FETCH-LOGICAL-c3811-4159f23255eb6fe51197f34bc05ed4cddfd5a13699c74e63a27287c5521d3f183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18390783$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McMillan, Nancy B.</creatorcontrib><creatorcontrib>Mulroy, Cecilia</creatorcontrib><creatorcontrib>MacKay, Mark W.</creatorcontrib><creatorcontrib>McDonald, Catherine M.</creatorcontrib><creatorcontrib>Jackson, W. Daniel</creatorcontrib><title>Correlation of Cholestasis With Serum Copper and Whole-Blood Manganese Levels in Pediatric Patients</title><title>Nutrition in clinical practice</title><addtitle>Nutr Clin Pract</addtitle><description>Many institutions reduce or eliminate copper (Cu) and manganese (Mn) in parenteral nutrition (PN) solutions when cholestasis develops. Little data exist to support this practice. Fifty-four subjects with known serum Cu, whole-blood Mn, and serum-conjugated bilirubin levels were evaluated in this prospective, observational study. Subjects ranged in weight from 760 g to 65.2 kg. Subjects weighing &lt;25 kg received a daily parenteral dose of 20μ g/kg Cu and 5 μg/kg Mn. Subjects weighing ≥25 kg received a dose of 500 μg/d Cu and 150 μg/d Mn. Cholestasis was defined as a conjugated bilirubin level ≥2 mg/dL. Of the 54 subjects, 20 had cholestasis. Fifteen patients had elevated Cu levels, and 21 had high Mn levels. Seven of the subjects had both high Cu and high Mn levels. The regression model comparing cholestasis as a predictor of high, low, or normal Cu level was not significant (P = .9588). Cholestasis was not a significant predictor of high, low, or normal Mn levels (P = .6533). No correlation between Cu and Mn levels was found. The authors found no significant relationship between conjugated serum bilirubin levels ≥2.0 mg/dL, serum Cu, and whole-blood Mn levels. They found insufficient evidence to support the practice of dosing Mn from a Cu level or vice versa. They recommend obtaining Cu and Mn levels on all pediatric patients who develop cholestasis prior to adjusting parenteral doses and at regular intervals for all long-term PN patients.</description><subject>Adolescent</subject><subject>Bilirubin - blood</subject><subject>Body Weight - physiology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>cholestasis</subject><subject>Cholestasis - blood</subject><subject>copper</subject><subject>Copper - administration &amp; dosage</subject><subject>Copper - blood</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Humans</subject><subject>Infant</subject><subject>Male</subject><subject>manganese</subject><subject>Manganese - administration &amp; dosage</subject><subject>Manganese - blood</subject><subject>Nursing</subject><subject>parenteral nutrition</subject><subject>Parenteral Nutrition - adverse effects</subject><subject>pediatric</subject><subject>Prospective Studies</subject><subject>Reference Values</subject><issn>0884-5336</issn><issn>1941-2452</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqFkM1LxDAQxYMoun7cPUlO3qqZpmnaoxa_YNUFlT2WbDJdI91mTVrF_94suyAI4mkY5vce8x4hx8DOAKQ8Z0WRCc5zVnDIRFpukRGUGSRpXLbJaHVOVvc9sh_CG2NQcFnskr04SyYLPiK6ct5jq3rrOuoaWr26FkOvgg10avtX-oR-WNDKLZfoqeoMna6I5LJ1ztB71c1VhwHpGD-wDdR2dILGqt5bTSfRFbs-HJKdRrUBjzbzgLxcXz1Xt8n48eauuhgnmhcASQaibFKeCoGzvEEBUMqGZzPNBJpMG9MYoYDnZallhjlXqUwLqYVIwfAmRjogp2vfpXfvQ0xRL2zQ2LbxRTeEWrIs5i5lBNka1N6F4LGpl94ulP-qgdWrYuvfxUbJycZ7mC3Q_Ag2TUZArIFP2-LXv4b1QzVhkEPUJWtdUHOs39zgu9jR3498A-wDjtw</recordid><startdate>200804</startdate><enddate>200804</enddate><creator>McMillan, Nancy B.</creator><creator>Mulroy, Cecilia</creator><creator>MacKay, Mark W.</creator><creator>McDonald, Catherine M.</creator><creator>Jackson, W. Daniel</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200804</creationdate><title>Correlation of Cholestasis With Serum Copper and Whole-Blood Manganese Levels in Pediatric Patients</title><author>McMillan, Nancy B. ; Mulroy, Cecilia ; MacKay, Mark W. ; McDonald, Catherine M. ; Jackson, W. Daniel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3811-4159f23255eb6fe51197f34bc05ed4cddfd5a13699c74e63a27287c5521d3f183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>Bilirubin - blood</topic><topic>Body Weight - physiology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>cholestasis</topic><topic>Cholestasis - blood</topic><topic>copper</topic><topic>Copper - administration &amp; dosage</topic><topic>Copper - blood</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Humans</topic><topic>Infant</topic><topic>Male</topic><topic>manganese</topic><topic>Manganese - administration &amp; dosage</topic><topic>Manganese - blood</topic><topic>Nursing</topic><topic>parenteral nutrition</topic><topic>Parenteral Nutrition - adverse effects</topic><topic>pediatric</topic><topic>Prospective Studies</topic><topic>Reference Values</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McMillan, Nancy B.</creatorcontrib><creatorcontrib>Mulroy, Cecilia</creatorcontrib><creatorcontrib>MacKay, Mark W.</creatorcontrib><creatorcontrib>McDonald, Catherine M.</creatorcontrib><creatorcontrib>Jackson, W. Daniel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nutrition in clinical practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McMillan, Nancy B.</au><au>Mulroy, Cecilia</au><au>MacKay, Mark W.</au><au>McDonald, Catherine M.</au><au>Jackson, W. Daniel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correlation of Cholestasis With Serum Copper and Whole-Blood Manganese Levels in Pediatric Patients</atitle><jtitle>Nutrition in clinical practice</jtitle><addtitle>Nutr Clin Pract</addtitle><date>2008-04</date><risdate>2008</risdate><volume>23</volume><issue>2</issue><spage>161</spage><epage>165</epage><pages>161-165</pages><issn>0884-5336</issn><eissn>1941-2452</eissn><abstract>Many institutions reduce or eliminate copper (Cu) and manganese (Mn) in parenteral nutrition (PN) solutions when cholestasis develops. Little data exist to support this practice. Fifty-four subjects with known serum Cu, whole-blood Mn, and serum-conjugated bilirubin levels were evaluated in this prospective, observational study. Subjects ranged in weight from 760 g to 65.2 kg. Subjects weighing &lt;25 kg received a daily parenteral dose of 20μ g/kg Cu and 5 μg/kg Mn. Subjects weighing ≥25 kg received a dose of 500 μg/d Cu and 150 μg/d Mn. Cholestasis was defined as a conjugated bilirubin level ≥2 mg/dL. Of the 54 subjects, 20 had cholestasis. Fifteen patients had elevated Cu levels, and 21 had high Mn levels. Seven of the subjects had both high Cu and high Mn levels. The regression model comparing cholestasis as a predictor of high, low, or normal Cu level was not significant (P = .9588). Cholestasis was not a significant predictor of high, low, or normal Mn levels (P = .6533). No correlation between Cu and Mn levels was found. The authors found no significant relationship between conjugated serum bilirubin levels ≥2.0 mg/dL, serum Cu, and whole-blood Mn levels. They found insufficient evidence to support the practice of dosing Mn from a Cu level or vice versa. They recommend obtaining Cu and Mn levels on all pediatric patients who develop cholestasis prior to adjusting parenteral doses and at regular intervals for all long-term PN patients.</abstract><cop>United States</cop><pub>SAGE Publications</pub><pmid>18390783</pmid><doi>10.1177/0884533608314529</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0884-5336
ispartof Nutrition in clinical practice, 2008-04, Vol.23 (2), p.161-165
issn 0884-5336
1941-2452
language eng
recordid cdi_proquest_miscellaneous_70483997
source Wiley-Blackwell Read & Publish Collection
subjects Adolescent
Bilirubin - blood
Body Weight - physiology
Child
Child, Preschool
cholestasis
Cholestasis - blood
copper
Copper - administration & dosage
Copper - blood
Dose-Response Relationship, Drug
Female
Humans
Infant
Male
manganese
Manganese - administration & dosage
Manganese - blood
Nursing
parenteral nutrition
Parenteral Nutrition - adverse effects
pediatric
Prospective Studies
Reference Values
title Correlation of Cholestasis With Serum Copper and Whole-Blood Manganese Levels in Pediatric Patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T10%3A07%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correlation%20of%20Cholestasis%20With%20Serum%20Copper%20and%20Whole-Blood%20Manganese%20Levels%20in%20Pediatric%20Patients&rft.jtitle=Nutrition%20in%20clinical%20practice&rft.au=McMillan,%20Nancy%20B.&rft.date=2008-04&rft.volume=23&rft.issue=2&rft.spage=161&rft.epage=165&rft.pages=161-165&rft.issn=0884-5336&rft.eissn=1941-2452&rft_id=info:doi/10.1177/0884533608314529&rft_dat=%3Cproquest_cross%3E70483997%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3811-4159f23255eb6fe51197f34bc05ed4cddfd5a13699c74e63a27287c5521d3f183%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70483997&rft_id=info:pmid/18390783&rft_sage_id=10.1177_0884533608314529&rfr_iscdi=true